GGrantIndex
← Search

PROTEOMIC BIOMARKERS FOR ALS DISEASE PROGNOSIS AND PROGRESSION MONITORING.

$1,117,328FY2025Defense Health AgencyDOD

The University Of Queensland

Investigators

View source on USAspending →
PROTEOMIC BIOMARKERS FOR ALS DISEASE PROGNOSIS AND PROGRESSION MONITORING. · GrantIndex